BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

742 related articles for article (PubMed ID: 16313928)

  • 1. The effect of IL-1alpha on the expression of matrix metalloproteinases, plasminogen activators, and their inhibitors in osteoblastic ROS 17/2.8 cells.
    Fujisaki K; Tanabe N; Suzuki N; Mitsui N; Oka H; Ito K; Maeno M
    Life Sci; 2006 Mar; 78(17):1975-82. PubMed ID: 16313928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of compressive force on the expression of MMPs, PAs, and their inhibitors in osteoblastic Saos-2 cells.
    Mitsui N; Suzuki N; Koyama Y; Yanagisawa M; Otsuka K; Shimizu N; Maeno M
    Life Sci; 2006 Jul; 79(6):575-83. PubMed ID: 16516240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of IL-1beta on the expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human chondrocytes.
    Aida Y; Maeno M; Suzuki N; Shiratsuchi H; Motohashi M; Matsumura H
    Life Sci; 2005 Nov; 77(25):3210-21. PubMed ID: 15979654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha.
    de Bart AC; Quax PH; Löwik CW; Verheijen JH
    J Bone Miner Res; 1995 Sep; 10(9):1374-84. PubMed ID: 7502710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of nicotine and lipopolysaccharide on the expression of matrix metalloproteinases, plasminogen activators, and their inhibitors in human osteoblasts.
    Katono T; Kawato T; Tanabe N; Tanaka H; Suzuki N; Kitami S; Morita T; Motohashi M; Maeno M
    Arch Oral Biol; 2009 Feb; 54(2):146-55. PubMed ID: 18986645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and localisation of extracellular matrix degrading proteases and their inhibitors during the oestrous cycle and after induced luteolysis in the bovine corpus luteum.
    Kliem H; Welter H; Kraetzl WD; Steffl M; Meyer HH; Schams D; Berisha B
    Reproduction; 2007 Sep; 134(3):535-47. PubMed ID: 17709571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progestin inhibits and thrombin stimulates the plasminogen activator/inhibitor system in term decidual stromal cells: implications for parturition.
    Norwitz ER; Snegovskikh V; Schatz F; Foyouzi N; Rahman M; Buchwalder L; Lee HJ; Funai EF; Buhimschi CS; Buhimschi IA; Lockwood CJ
    Am J Obstet Gynecol; 2007 Apr; 196(4):382.e1-8. PubMed ID: 17403427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts.
    Allan EH; Martin TJ
    J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of extracellular matrix components in the bovine oviduct during the oestrous cycle.
    Gabler C; Killian GJ; Einspanier R
    Reproduction; 2001 Jul; 122(1):121-30. PubMed ID: 11425336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
    Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
    Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V
    Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The plasminogen-MMP system is more activated in the scar than in viable myocardium 3 months post-MI in the rat.
    Gaertner R; Jacob MP; Prunier F; Angles-Cano E; Mercadier JJ; Michel JB
    J Mol Cell Cardiol; 2005 Jan; 38(1):193-204. PubMed ID: 15623436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-1beta enhances the angiotensin-induced expression of plasminogen activator inhibitor-1 through angiotensin receptor upregulation in human astrocytes.
    Yoshida H; Imaizumi T; Tanji K; Sakaki H; Metoki N; Sato Y; Wakabayashi K; Kimura H; Satoh K
    Brain Res; 2006 Feb; 1073-1074():38-47. PubMed ID: 16427616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-activating factor induces the gene expression of TIMP-1, -2, and PAI-1: imbalance between the gene expression of MMP-9 and TIMP-1 and -2.
    Ottino P; Taheri F; Bazan HE
    Exp Eye Res; 2002 Mar; 74(3):393-402. PubMed ID: 12014920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased TIMP/MMP ratio in varicose veins: a possible explanation for extracellular matrix accumulation.
    Badier-Commander C; Verbeuren T; Lebard C; Michel JB; Jacob MP
    J Pathol; 2000 Sep; 192(1):105-12. PubMed ID: 10951407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
    Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of matrix metalloproteinases-1, -2, and -9; tissue inhibitors of matrix metalloproteinases-1 and -2; cathepsin B; urokinase plasminogen activator; and plasminogen activator inhibitor, type I in skull base chordoma.
    Naka T; Kuester D; Boltze C; Schulz TO; Samii A; Herold C; Ostertag H; Roessner A
    Hum Pathol; 2008 Feb; 39(2):217-23. PubMed ID: 17949787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-1alpha affects mineralized nodule formation by rat osteoblasts.
    Tanabe N; Ito-Kato E; Suzuki N; Nakayama A; Ogiso B; Maeno M; Ito K
    Life Sci; 2004 Sep; 75(19):2317-27. PubMed ID: 15350829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and localization of extracellular matrix-degrading proteinases and their inhibitors in the bovine mammary gland during development, function, and involution.
    Rabot A; Sinowatz F; Berisha B; Meyer HH; Schams D
    J Dairy Sci; 2007 Feb; 90(2):740-8. PubMed ID: 17235151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrocortisone regulates the dynamics of plasminogen activator and plasminogen activator inhibitor expression in cultured murine keratinocytes.
    Bator JM; Cohen RL; Chambers DA
    Exp Cell Res; 1998 Jul; 242(1):110-9. PubMed ID: 9665808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.